Study/Author | Death | Stroke | Re-infarction | Target vessel revascularization | ||||
---|---|---|---|---|---|---|---|---|
 | Thrombectomy | Control | Thrombectomy | Control | Thrombectomy | Control | Thrombectomy | Control |
Svilaas | 2% | 4% | 0% | 0% | 1% | 2% | 5% | 6% |
 | 11 | 21 | 0 | 0 | 4 | 10 | 24 | 31 |
AIMI | 5% | 1% | 1.7% | 0.8% | 0% | 0% | 2% | 0.4% |
 | 11 | 2 | 4 | 2 | 0 | 0 | 5 | 1 |
DEAR-MI | 0% | 0% | 0% | 0% | 0% | 0% | 1.4% | 0% |
 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
Kaltoft | 0% | 1% | 1.9% | 0% | 0% | 1% | Â | Â |
 | 0 | 1 | 2 | 0 | 0 | 1 | N/A | N/A |
De Luca | 0% | 5% | 0% | 0% | 3% | 0% | Â | Â |
 | 0 | 2 |  |  | 1 | 0 | N/A | N/A |
X-AMINE | 4% | 4% | 2% | 0% | 1% | 3% | 2% | 0% |
ST | 4 | 4 | 2 | 0 | 1 | 3 | 2 | 0 |
REMEDIA | 6% | 6% | 2.1% | 2.1% | 4% | 4% | 2.1% | 2.1% |
 | 3 | 3 | 1 | 1 | 2 | 2 | 1 | 1 |
VAMPIRE | 1% | 1% | Â | Â | 0% | 1% | 0% | 1% |
 | 1 | 1 | N/A | N/A | 0 | 1 | 0 | 1 |
EXPORT | 0% | 4% | Â | Â | Â | Â | Â | Â |
 | 0 | 1 | N/A | N/A | N/A | N/A | N/A | N/A |
Dudek | Â | Â | Â | Â | Â | Â | Â | Â |
 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Antoniucci | 0% | 0% | 2% | 0% | 0% | 0% | 0% | 0% |
 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
NON | 1% | 1.5% | Â | Â | Â | Â | Â | Â |
STOP | 2 | 2 | N/A | N/A | N/A | N/A | N/A | N/A |
Napodano | 7% | 7% | 0% | 0% | 4% | 4% | 0% | 0% |
 | 3 | 3 | 0 | 0 | 2 | 2 | 0 | 0 |
Beran | 7% | 3% | Â | Â | Â | Â | 0% | 3% |
 | 2 | 1 | N/A | N/A | N/A | N/A | 0 | 1 |
Chevalier | 3% | 4% | 2% | 0% | 3% | 1% | 0% | 0% |
 | 4 | 5 | 2 | 0 | 3 | 1 | 0 | 0 |
EXPIRA | 0% | 1% | 2% | 0% | 0% | 0% | N/A | N/A |
 | 0 | 1 | 2 | 0 | 0 | 0 |  |  |
PIHRATE | 3% | 3% | N/A | N/A | 0% | 1% | 2% | 1% |
 | 3 | 3 |  |  | 0 | 1 | 2 | 1 |